| Size | Price | Stock | Qty |
|---|---|---|---|
| 1mg |
|
||
| 5mg |
|
||
| Other Sizes |
| Targets |
5-Formylcytidine does not have a defined pharmacological target as it is a biochemical reagent and nucleoside analog. The compound is a modified nucleoside that can be used to study epigenetic modifications and nucleic acid chemistry. As a pyrimidine nitrogen base derived from cytosine, it may be used in research on DNA and RNA modifications.
|
|---|---|
| ln Vitro |
No specific in vitro pharmacological activity data are available for 5-Formylcytidine as a drug candidate. In research settings, the compound is used as a biochemical reagent for studying nucleic acid modifications. Its activity is assessed in terms of its role as a modified nucleoside and its chemical properties rather than direct biological activity.
|
| ln Vivo |
No specific in vivo pharmacological activity data have been documented for 5-Formylcytidine as a therapeutic agent. The compound is used as a biochemical reagent and nucleoside analog. It is not administered to animals for pharmacological evaluation. Its applications are limited to nucleic acid chemistry and epigenetic research.
|
| Enzyme Assay |
For non-cellular assays, 5-Formylcytidine is characterized by standard analytical techniques including HPLC, NMR, and mass spectrometry to confirm identity and purity. Purity is typically >95% by HPLC. The compound has a molecular weight of 271.23 and formula C₁₀H₁₃N₃O₆. Storage: -20°C, sealed storage, away from moisture; in solvent at -80°C for 6 months or -20°C for 1 month.
|
| Cell Assay |
For in vitro cell-based studies, 5-Formylcytidine is not typically used as a direct test compound. It is used as a biochemical reagent for studying nucleic acid modifications. If handled in a biological laboratory context, standard safety precautions should be taken. The compound should be stored in a sealed, protected environment away from moisture.
|
| Animal Protocol |
For in vivo animal studies, 5-Formylcytidine can be formulated using standard injection vehicles. The compound is a solid at room temperature. Dosing solutions should be freshly prepared and administered according to specific protocols with appropriate control groups. Standard handling procedures for nucleosides should be followed.
|
| ADME/Pharmacokinetics |
5-Formylcytidine has a molecular weight of 271.23 and formula C₁₀H₁₃N₃O₆. Purity: >95% by HPLC. Storage: -20°C, sealed storage, away from moisture; in solvent at -80°C for 6 months or -20°C for 1 month. The compound is a solid at room temperature. Solubility: soluble in appropriate solvents.
|
| Toxicity/Toxicokinetics |
5-Formylcytidine is for research use only and not for human consumption. Standard laboratory safety practices should be followed when handling this chemical. Appropriate personal protective equipment including gloves and safety glasses should be worn. Specific LD₅₀ values and detailed toxicological profiles have not been extensively reported.
|
| References | |
| Additional Infomation |
5-Formylcytidine is a nucleoside analogue, a product of cytidine with a formyl group substituted at the 5-position. It is both an aldehyde and a nucleoside analogue, functionally related to cytidine. It is located at the first position of the anticodon of methionine tRNA in bovine liver mitochondria; its structure is described in the earliest literature report.
5-Formylcytidine (CAS 148608-53-1) is also known as 5-formylcytosine and cytidine, 5-formyl-. It is a pyrimidine nitrogen base developed from cytosine used as a biochemical reagent for nucleic acid research. No clinical trials or therapeutic approvals exist. |
| Molecular Formula |
C10H13N3O6
|
|---|---|
| Molecular Weight |
271.23
|
| Exact Mass |
271.08
|
| CAS # |
148608-53-1
|
| PubChem CID |
132842
|
| Appearance |
White to off-white solid powder
|
| Density |
1.91g/cm3
|
| Boiling Point |
594.9ºC at 760mmHg
|
| Flash Point |
313.6ºC
|
| Vapour Pressure |
1.24E-16mmHg at 25°C
|
| Index of Refraction |
1.755
|
| LogP |
-2.2
|
| Hydrogen Bond Donor Count |
4
|
| Hydrogen Bond Acceptor Count |
6
|
| Rotatable Bond Count |
3
|
| Heavy Atom Count |
19
|
| Complexity |
462
|
| Defined Atom Stereocenter Count |
4
|
| SMILES |
C1=C(C(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N)C=O
|
| InChi Key |
OCMSXKMNYAHJMU-JXOAFFINSA-N
|
| InChi Code |
InChI=1S/C10H13N3O6/c11-8-4(2-14)1-13(10(18)12-8)9-7(17)6(16)5(3-15)19-9/h1-2,5-7,9,15-17H,3H2,(H2,11,12,18)/t5-,6-,7-,9-/m1/s1
|
| Chemical Name |
4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidine-5-carbaldehyde
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.6869 mL | 18.4345 mL | 36.8691 mL | |
| 5 mM | 0.7374 mL | 3.6869 mL | 7.3738 mL | |
| 10 mM | 0.3687 mL | 1.8435 mL | 3.6869 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
